Toggle navigation
Home
About Us
Pipeline
Collaborations
Investors
Media Center
News Releases
Publications
Events
Careers
Contact Us
Site Map
Home
About Us
Pipeline
Collaborations
Investors
Media Center
News Releases
Publications
Events
Careers
Media Center
News Releases
Publications
Press Releases
Title Filter
Display #
5
10
15
20
25
30
50
100
All
Lexicon Pharmaceuticals Announces Real-World Data on Telotristat Ethyl’s Antiproliferative Effects in Patients with Carcinoid Syndrome
Jan 24, 2020
Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium
Jan 20, 2020
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
Jan 06, 2020
Lexicon Pharmaceuticals Announces Topline Phase 3 Data for Sotagliflozin in Type 2 Diabetes
Dec 20, 2019
Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211
Dec 05, 2019
Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of Tele-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer
Dec 03, 2019
Lexicon Pharmaceuticals Receives Formal Dispute Resolution Request Decision from FDA’s Office of New Drugs for Sotagliflozin in Type 1 Diabetes
Dec 02, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
Nov 26, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
Nov 14, 2019
Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update
Nov 07, 2019
1
2
3
4
...
6
7
8
9
10
Copyright
©
2020, Lexicon Pharmaceuticals, Inc. All Rights Reserved
Privacy Policy
Terms of Use
Vendor Terms
Contact Us
Sitemap